OhMD is an AI-enabled HIPAA-compliant patient communication platform that reduces high patient call volume for physician practices.
OhMD has raised $4.5M in total funding. The most recent round was Seed. The last funding was announced in February 2022.
OhMD's investors include FCA Venture Partners, GE Healthcare, Marathon Health, OpenTempo, Blueprint Health.
OhMD is headquartered in Burlington, United States.
OhMD is an AI-enabled HIPAA-compliant patient communication platform that reduces high patient call volume for physician practices.
OhMD is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OhMD — Funding & Investors." VCBacked, February 22, 2022, https://www.vcbacked.co/company/ohmd. Accessed August 13, 2026.
VCBacked. (2022). OhMD — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/ohmd
{{cite web |title=OhMD — Funding & Investors |url=https://www.vcbacked.co/company/ohmd |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated